BioMarin to Participate in Upcoming Virtual Investor Conference

Rhea-AI Summary

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) has announced that Brian Mueller, Executive Vice President and Chief Financial Officer, will participate in Morningstar's Management Behind the Moat Conference on September 30, 2020, at 1:00 PM ET. The conference will be accessible through a live audio webcast, which can be found on the company's investor relations website. An archived version will also be available for a limited time. BioMarin specializes in developing therapies for serious rare disorders and has six commercial products along with several candidates in its portfolio.

News Market Reaction – BMRN

-2.55%

-2.55% Session move

In the trading session that priced this news, BMRN declined 2.55%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SAN RAFAEL, Calif., Sept. 29, 2020 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Brian Mueller, Executive Vice President, Chief Financial Officer, will participate in Morningstar's Management Behind the Moat Conference on September 30, 2020 at 1:00pm ET. An audio webcast of the presentation will be available live. You can access the webcast at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference.

About BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates.  

For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.

Contacts:
Investors	Media
Traci McCarty	Debra Charlesworth
BioMarin Pharmaceutical Inc.	BioMarin Pharmaceutical Inc.
(415) 455-7558	(415) 455-7451

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/biomarin-to-participate-in-upcoming-virtual-investor-conference-301139652.html

SOURCE BioMarin Pharmaceutical Inc.

FAQ

What is BioMarin's participation in the Morningstar Conference?

BioMarin will have Brian Mueller participate in Morningstar's Management Behind the Moat Conference on September 30, 2020, at 1:00 PM ET.

Where can I access the BioMarin conference webcast?

The live audio webcast of BioMarin's conference presentation can be accessed on their investor relations website.

What time is BioMarin's conference presentation scheduled?

BioMarin's conference presentation is scheduled for September 30, 2020, at 1:00 PM ET.

What type of products does BioMarin develop?

BioMarin develops innovative therapies for serious and life-threatening rare disorders, with six commercialized products and multiple candidates.

Will there be a recording of the BioMarin conference?

Yes, an archived version of the conference remarks will be available for a limited time after the presentation.